# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-25-132736
Filing Date
2025-06-02
Accepted
2025-06-02 06:36:56
Documents
47
Period of Report
2025-06-02
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d916346d8k.htm iXBRL | 8-K | 34394
2 | EX-99.1 | d916346dex991.htm | EX-99.1 | 19563
3 | EX-99.2 | d916346dex992.htm | EX-99.2 | 37550
7 | GRAPHIC | g916346ex99_2p10g1.jpg | GRAPHIC | 179406
8 | GRAPHIC | g916346ex99_2p11g1.jpg | GRAPHIC | 335690
9 | GRAPHIC | g916346ex99_2p12g1.jpg | GRAPHIC | 254676
10 | GRAPHIC | g916346ex99_2p13g1.jpg | GRAPHIC | 106044
11 | GRAPHIC | g916346ex99_2p14g1.jpg | GRAPHIC | 225556
12 | GRAPHIC | g916346ex99_2p15g1.jpg | GRAPHIC | 181771
13 | GRAPHIC | g916346ex99_2p16g1.jpg | GRAPHIC | 237676
14 | GRAPHIC | g916346ex99_2p17g1.jpg | GRAPHIC | 412782
15 | GRAPHIC | g916346ex99_2p18g1.jpg | GRAPHIC | 98053
16 | GRAPHIC | g916346ex99_2p19g1.jpg | GRAPHIC | 221097
17 | GRAPHIC | g916346ex99_2p1g1.jpg | GRAPHIC | 149887
18 | GRAPHIC | g916346ex99_2p20g1.jpg | GRAPHIC | 282653
19 | GRAPHIC | g916346ex99_2p21g1.jpg | GRAPHIC | 287838
20 | GRAPHIC | g916346ex99_2p22g1.jpg | GRAPHIC | 204639
21 | GRAPHIC | g916346ex99_2p23g1.jpg | GRAPHIC | 275938
22 | GRAPHIC | g916346ex99_2p24g1.jpg | GRAPHIC | 111088
23 | GRAPHIC | g916346ex99_2p25g1.jpg | GRAPHIC | 268046
24 | GRAPHIC | g916346ex99_2p26g1.jpg | GRAPHIC | 102460
25 | GRAPHIC | g916346ex99_2p27g1.jpg | GRAPHIC | 258935
26 | GRAPHIC | g916346ex99_2p28g1.jpg | GRAPHIC | 250854
27 | GRAPHIC | g916346ex99_2p29g1.jpg | GRAPHIC | 251520
28 | GRAPHIC | g916346ex99_2p2g1.jpg | GRAPHIC | 564782
29 | GRAPHIC | g916346ex99_2p30g1.jpg | GRAPHIC | 180464
30 | GRAPHIC | g916346ex99_2p31g1.jpg | GRAPHIC | 174453
31 | GRAPHIC | g916346ex99_2p32g1.jpg | GRAPHIC | 160876
32 | GRAPHIC | g916346ex99_2p3g1.jpg | GRAPHIC | 390974
33 | GRAPHIC | g916346ex99_2p4g1.jpg | GRAPHIC | 186002
34 | GRAPHIC | g916346ex99_2p5g1.jpg | GRAPHIC | 219294
35 | GRAPHIC | g916346ex99_2p6g1.jpg | GRAPHIC | 324340
36 | GRAPHIC | g916346ex99_2p7g1.jpg | GRAPHIC | 228524
37 | GRAPHIC | g916346ex99_2p8g1.jpg | GRAPHIC | 96952
38 | GRAPHIC | g916346ex99_2p9g1.jpg | GRAPHIC | 344597
39 | GRAPHIC | g916346g0601152436858.jpg | GRAPHIC | 3258
| Complete submission text file | 0001193125-25-132736.txt |  | 10661377

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | vera-20250602.xsd | EX-101.SCH | 2834
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | vera-20250602_lab.xml | EX-101.LAB | 17993
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | vera-20250602_pre.xml | EX-101.PRE | 11250
49 | EXTRACTED XBRL INSTANCE DOCUMENT | d916346d8k_htm.xml | XML | 3658

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40407 | Film No.: 251013085
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)